British healthcare stakeholders present collaborative biosimilars document

Several British healthcare stakeholders have joined forces on biosimilars.

The Association of the British Pharmaceutical Industry (ABPI), the UK BioIndustry Association (BIA) and the British Generic Manufacturers Association (BGMA) have welcomed NHS England’s new publication “What is a biosimilar medicine?”

The publication came from collaboration between the Medicines and Healthcare product Regulatory Agency (MHRA), NHS England, the National Institute of Health and Care Excellence (NICE) and the pharma industry trade associations. It is the first national-level collaborative publication on biosimilars, and follows the European Commission’s 2013 consensus document “What you need to know about biosimilar medicinal products.”